ArticleFrontiers in transplantation2023

Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy.

Aurélie Philippe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.